Stockscreener 앱 받기
1.90
7.32%
-0.15
시간 외 거래:
1.93
0.03
+1.58%
전일 마감가:
$2.05
열려 있는:
$2
하루 거래량:
574.29K
Relative Volume:
0.06
시가총액:
$30.42M
수익:
$1.38M
순이익/손실:
$-179.05M
주가수익비율:
-0.3094
EPS:
-6.14
순현금흐름:
$-155.03M
1주 성능:
-16.67%
1개월 성능:
-24.90%
6개월 성능:
+6.74%
1년 성능:
+195.44%
1일 변동 폭
$1.90
$2.00
1주일 범위
$1.90
$2.288
52주 변동 폭
$0.16
$8.08
바이오엑셀 테라퓨틱스 Stock (BTAI) Company Profile
명칭
Bioxcel Therapeutics Inc
전화
203-643-8060
주소
555 LONG WHARF DRIVE, NEW HAVEN, CT
BTAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
1.90 | 40.28M | 1.38M | -179.05M | -155.03M | -6.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
바이오엑셀 테라퓨틱스 Stock (BTAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-21 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-15 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2023-07-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-03-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-12-01 | 업그레이드 | Goldman | Sell → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-06 | 재확인 | BofA Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-09 | 개시 | Berenberg | Buy |
| 2021-02-01 | 개시 | UBS | Buy |
| 2020-10-30 | 개시 | Goldman | Buy |
| 2020-09-02 | 개시 | Jefferies | Buy |
| 2020-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-04 | 개시 | Guggenheim | Buy |
| 2020-04-01 | 개시 | BofA/Merrill | Buy |
| 2020-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-12 | 개시 | SunTrust | Buy |
모두보기
바이오엑셀 테라퓨틱스 주식(BTAI)의 최신 뉴스
Why BioXcel Therapeutics Inc. stock remains on buy listsPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
Why BioXcel Therapeutics Inc. stock could see breakout soonWeekly Investment Summary & Accurate Trade Setup Notifications - newser.com
What dividend safety score for BioXcel Therapeutics Inc. stockWall Street Watch & Risk Managed Investment Signals - newser.com
Can BioXcel Therapeutics Inc. stock beat market expectations this quarter2025 Performance Recap & Community Trade Idea Sharing - newser.com
Does BioXcel Therapeutics Inc. show high probability of reboundQuarterly Market Summary & Low Risk High Reward Trade Ideas - newser.com
Published on: 2025-11-03 03:37:33 - newser.com
Will BioXcel Therapeutics Inc. stock benefit from automationPortfolio Value Summary & High Yield Stock Recommendations - newser.com
Published on: 2025-11-03 01:00:44 - newser.com
Published on: 2025-11-03 00:33:12 - newser.com
How BioXcel Therapeutics Inc. stock reacts to Fed rate cutsCEO Change & Weekly Return Optimization Alerts - newser.com
Tools to monitor BioXcel Therapeutics Inc. recovery probabilityQuarterly Earnings Summary & Fast Momentum Entry Tips - newser.com
Will BioXcel Therapeutics Inc. (BX20) stock recover faster than industry2025 Big Picture & Verified Entry Point Signals - newser.com
Why BioXcel Therapeutics Inc. stock remains a top recommendationGap Up & Low Risk Entry Point Guides - newser.com
Published on: 2025-11-02 05:48:35 - newser.com
Is BioXcel Therapeutics Inc. (BX20) stock bottoming after sell off2025 Market Outlook & Smart Swing Trading Alerts - newser.com
Published on: 2025-11-01 08:49:34 - newser.com
Can you recover from losses in BioXcel Therapeutics Inc.2025 Support & Resistance & Low Risk Profit Maximizing Plans - newser.com
How analysts revise price targets for BioXcel Therapeutics Inc. (BX20) stockJuly 2025 EndofMonth & Precise Swing Trade Entry Alerts - newser.com
Leading vs lagging indicators on BioXcel Therapeutics Inc. performanceVolume Spike & Real-Time Stock Price Movement Reports - newser.com
BTAI sets Dec 12 virtual annual meeting; board backs all items - Stock Titan
Analysts Are Bullish on These Healthcare Stocks: Bioxcel Therapeutics (BTAI), Perspective Therapeutics (CATX) - The Globe and Mail
Will BioXcel Therapeutics Inc. benefit from macro trendsAnalyst Upgrade & Daily Profit Focused Stock Screening - newser.com
How BioXcel Therapeutics Inc. (BX20) stock reacts to stronger dollarBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
Key metrics from BioXcel Therapeutics Inc.’s quarterly dataDay Trade & AI Enhanced Execution Alerts - newser.com
Building trade automation scripts for BioXcel Therapeutics Inc.2025 Risk Factors & Growth Focused Investment Plans - newser.com
BioXcel Therapeutics Updates sNDA Timeline for IGALMI® - MSN
BioXcel Therapeutics Updates on IGALMI® sNDA Submission - TradingView
BioXcel Therapeutics IncUpdates On sNDA Submission For IGALMI Label ExpansionSEC Filing - TradingView
바이오엑셀 테라퓨틱스 (BTAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):